RDO patient pathway improves operative rates in cataracts

Article

Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient pathway, compared to the GP pathway, reveals a recent investigation in the UK.

Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient pathway, compared to the GP pathway, reveals a recent investigation in the UK.

A retrospective cohort study led by Dr Kevin Holmes, Bristol, and the Plymouth Royal Eye Infirmary, Plymouth, UK, was conducted on 4657 patients referred to the “One-stop cataract clinic” at Bristol Eye Hospital between 1 November 2008 and 31 May 2010.

Of the patients in the cohort, 4222 were referred via the traditional GP route and 435 were referred via the new refined direct optometrist (RDO) route. The team compared the operative rate, which was identified as the conversion to surgery from referral.

Operative rates were higher for the RDO pathway, compared to the GP pathway at 91.9% and 82.4%, respectively. Combining referral information from optometrists and GPs creates a high-quality and efficient cataract surgery patient pathway.

Combining referral information also had major economic advantages and could be adopted at a national level in the UK.

The abstract can be found in the latest issue of the Journal of Cataract and Refractive Surgery.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.